Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy

Meilin Jiang, Wenying Peng, Xingxiang Pu, Bolin Chen, Jia Li, Fang Xu, Liyu Liu, Li Xu, Yan Xu, Jun Cao, Qianzhi Wang, Kang Li, Jingyi Wang, Lin Wu

Open source

DOI: 10.3389/fonc.2020.00913
Published: 2020-06-30
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2020.00913,
  title = {Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy},
  author = {Meilin Jiang and Wenying Peng and Xingxiang Pu and Bolin Chen and Jia Li and Fang Xu and Liyu Liu and Li Xu and Yan Xu and Jun Cao and Qianzhi Wang and Kang Li and Jingyi Wang and Lin Wu},
  year = {2020},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2020.00913},
  url = {https://doi.org/10.3389/fonc.2020.00913}
}

RIS

TY  - JOUR
TI  - Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
AU  - Meilin Jiang
AU  - Wenying Peng
AU  - Xingxiang Pu
AU  - Bolin Chen
AU  - Jia Li
AU  - Fang Xu
AU  - Liyu Liu
AU  - Li Xu
AU  - Yan Xu
AU  - Jun Cao
AU  - Qianzhi Wang
AU  - Kang Li
AU  - Jingyi Wang
AU  - Lin Wu
PY  - 2020
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2020.00913
UR  - https://doi.org/10.3389/fonc.2020.00913
ER  -

APA

Jiang, M., Peng, W., Pu, X., Chen, B., Li, J., Xu, F., Liu, L., Xu, L., Xu, Y., Cao, J., Wang, Q., Li, K., Wang, J., & Wu, L. (2020). Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy. Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.00913

Source records

crossref · retrieved 2026-09-24T21:23:48.325Z